Skip to main content
. 2023 Feb 13;14:1116839. doi: 10.3389/fimmu.2023.1116839

Figure 9.

Figure 9

Correlation analysis of treatment response. (A) Immune typing of high and low-risk groups. (B) The difference in TIDE scores between high and low-risk groups. (C) The relationship between SRG risk scores and positive immune checkpoint blockade (ICB) related signals. (D) CHI3L1 and ATP6AP1 may affect the prognosis of patients by changing the state of the tumor microenvironment. (E) Differences in IPS reactivity between high and low-risk groups. ***P<0.001.